Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Diane, Vulliémoz"'
Publikováno v:
Journal of General Virology. 86:171-180
The genomic and antigenomic 3′ ends of the Sendai virus replication promoters are bi-partite in nature. They are symmetrically composed of leader or trailer sequences, a gene start (gs) or gene end (ge) site, respectively, and a simple hexameric re
Autor:
Laurent Roux, Diane Vulliémoz
Publikováno v:
Journal of Virology. 76:7987-7995
The negative-stranded RNA viral genome is an RNA-protein complex of helicoidal symmetry, resistant to nonionic detergent and high salt, in which the RNA is protected from RNase digestion. The 15,384 nucleotides of the Sendai virus genome are bound to
Autor:
Laurent Roux, Diane Vulliémoz
Publikováno v:
Journal of Virology. 75:4506-4518
The “rule of six” stipulates that the Paramyxovirus RNA polymerase efficiently replicates only viral genomes counting 6 n + 0 nucleotides. Because the nucleocapsid proteins (N) interact with 6 nucleotides, an exact nucleotide-N match at the RNA 3
Autor:
Nicolas, Leupin, Jean, Bauer, François, Lüthi, Danielle, Liénard, Diane, Vulliémoz, S, Leyvraz
Publikováno v:
Revue medicale suisse. 1(20)
Advances in cancer biology have led to the development of screening tests that allow an early diagnosis. Cancer screening is not just the matter of a single individual patient, it is a matter of public health. Screening is commonly viewed as of no ha
Publikováno v:
Revue medicale suisse. 1(20)
These last decades showed important progress in cancer systemic therapies. A better understanding of the differences between cancer cells and normal cells lead to the emergence of targeted therapies. These treatments interfere with different specific
Autor:
Isabel, Filges, Khalil, Zaman, Olivier, Michielin, Diane, Vulliémoz, Lucien, Perey, Roger, Stupp
Publikováno v:
Revue medicale suisse. 1(20)
Cancer chemoprevention is defined as the use of natural or synthetic agents to reverse, suppress or prevent carcinogenic progression to invasive cancer. The success of several clinical trials within high-risk patients suggests that chemoprevention is